Targeting the Cell Cycle to Safeguard Hope: The Clinical Value and...

adicionou um novo artigo Health

2026-01-30 09:20:29 -

Targeting the Cell Cycle to Safeguard Hope: The Clinical Value and Development of CDK4/6 Inhibitors

Written by DengyuePharma As cancer treatment enters the era of precision medicine, the emergence of each novel targeted therapy has brought renewed hope to countless patients. CDK4/6 inhibitors, a class of targeted agents focusing on cell cycle regulation, have established a central role in the treatment of hormone receptor–positive (HR+), human epidermal growth factor receptor...

0 Comentários 0 Compartilhamentos 192 Visualizações 0 Anterior